Concert Pharmaceuticals, Inc. Employee Directory

Pharmaceutical ManufacturingMassachusetts, United States51-200 Employees

Concert Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Lexington, Massachusetts, focused on discovering and developing small molecule drugs through its DCE Platform, which uses selective incorporation of deuterium into existing molecules. This approach aims to improve pharmacokinetic and metabolic properties on a case-by-case basis, potentially enhancing safety, tolerability, or efficacy. Its lead candidate is in late-stage development for alopecia areata, an autoimmune dermatological condition, with additional earlier-stage pipeline programs under evaluation. The work sits within the pharmaceutical manufacturing landscape, pursuing programs that leverage deuterium-based design to optimize drug properties. In 2022, Concert entered into an agreement with Terran Biosciences to transfer a portfolio of CNS therapeutics and accompanying intellectual property.

Sign up for free to view info

Company overview Email format